002317.SZ · 众生药业
China A-shares · RS rating 92 · As of 2026-10-14
| Price | 27.01 CNY |
|---|---|
| 1-day change | +6.0% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 92 / 52 / 91 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 43 / 50 / 31 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -39.7% |
| Distance from 52-week high | +18.9% |
| Market cap (USD) | $3.2B |